Written Question·Department of Health and Social Care·UIN 62450

Vamorolone

Tabled: 24 June 2025

Answered: 30 June 2025

Named Day

Question

Freddie van Mierlo

To ask the Secretary of State for Health and Social Care, how many patients have accessed Vamorolone since it was given NICE approval for Duchenne Muscular Dystrophy; what assessment he has made of the adequacy of availability of Vamorolone to patients wi

Answer

Karin Smyth

The National Institute for Health and Care Excellence (NICE) published its technology appraisal, titled Vamorolone for treating Duchenne muscular dystrophy in people 4 years and over, on 16 January 2025. NHS England routinely commissioned vamorolone in li...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 62450) →